1. Krakauer EL, et al. Opioid inaccessibility and its human consequences: reports from the field. J Pain Palliat Care Pharmacother. 2010;24(3):239–43. Accessible at:
http://informahealthcare.com/doi/abs/10.3109/15360288.2010.501852
. Accessed 11 Oct 2012.
2. International Narcotics Control Board. Demand for and supply of opiates for medical and scientific needs. In: Report of the International Narcotics Control Board for 1989. New York: United Nations; 1989.
3. World Health Organization. mhGAP Mental Health Gap Action Programme. Scaling up care for mental, neurological, and substance use disorders. Geneva. 2008. Accessible at:
http://whqlibdoc.who.int/publications/2008/9789241596206_eng.pdf
. Accessed 12 Oct 2012.
4. International Narcotics Control Board. Report of the International Narcotics Control Board on the availability of internationally controlled drugs: ensuring adequate access for medical and scientific purposes. New York; 2011, E/INCB/2010/1/Supp.1. ISBN 978-92-1-148260-7. Accessible at:
http://www.incb.org/documents/Publications/AnnualReports/AR10_Supp_E.pdf
. Accessed 11 Oct 2012.
5. World Health Organization. Access to Controlled Medications Programme: improving access to medications under international drug conventions: briefing note. Geneva. 2012. Accessible at:
http://www.who.int/entity/medicines/areas/quality_safety/ACMP_BrNote_Genrl_EN_Apr2012.pdf
. Accessed 8 June 2013.